{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T19:24:33Z","timestamp":1749151473996},"publisher-location":"Cham","reference-count":15,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319419282"},{"type":"electronic","value":"9783319419299"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-41929-9_51","type":"book-chapter","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T10:32:49Z","timestamp":1467369169000},"page":"555-562","source":"Crossref","is-referenced-by-count":1,"title":["Cytotoxic Drug Manipulation and Its Impact on Occupational Safety of Hospital Workers"],"prefix":"10.1007","author":[{"given":"Jo\u00e3o","family":"Silva","sequence":"first","affiliation":[]},{"given":"Pedro M.","family":"Arezes","sequence":"additional","affiliation":[]},{"given":"Rudolf","family":"Schierl","sequence":"additional","affiliation":[]},{"given":"N\u00e9lson","family":"Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,7,2]]},"reference":[{"key":"51_CR1","unstructured":"Silva, J.: Manipula\u00e7\u00e3o de citost\u00e1ticos num hospital: estudo do impacto sobre a contamina\u00e7\u00e3o do ambiente ocupacional. Master thesis, Minho University (2011)"},{"key":"51_CR2","unstructured":"MSC, Minist\u00e9rio de Sanidad Y Consumo: Protocolo de Vigil\u00e2ncia Sanit\u00e1ria Especifica para los trabajadores expuestos a Agentes Citost\u00e1ticos. Page 14, Madrid (2003)"},{"key":"51_CR3","doi-asserted-by":"crossref","unstructured":"Polovich, M.: Developing a hazardous drug safe-handling program. Commun. Oncol. 2 (2005)","DOI":"10.1016\/S1548-5315(11)70613-1"},{"issue":"1","key":"51_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.rpsp.2011.12.002","volume":"30","author":"A Suspiro","year":"2012","unstructured":"Suspiro, A., Prista, J.: Exposi\u00e7\u00e3o ocupacional a citost\u00e1ticos e efeitos sobre a sa\u00fade. Revista Portuguesa de Saude Publica 30(1), 76\u201388 (2012)","journal-title":"Revista Portuguesa de Saude Publica"},{"key":"51_CR5","unstructured":"NIOSH, National Institute for Occupational Safety and Health: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings (2004)"},{"issue":"4","key":"51_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00002018-199920040-00004","volume":"20","author":"PJM Sessink","year":"1999","unstructured":"Sessink, P.J.M., Bos, R.P.: Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug Saf. 20(4), 347\u2013359 (1999)","journal-title":"Drug Saf."},{"key":"51_CR7","unstructured":"Infarmed, Medicamentos antineopl\u00e1sicos e imunomoduladores. http:\/\/www.infarmed.pt\/formulario\/navegacao.php?paiid=266 . Last accessed 2014\/04\/18 (2014)"},{"issue":"7","key":"51_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/annhyg\/mep050","volume":"53","author":"R Schierl","year":"2009","unstructured":"Schierl, R., B\u00f6hlandt, A., Nowak, D.: Guidance values for surface monitoring of antineoplastic drugs in german pharmacies. Ann. Occup. Hyg. 53(7), 703\u2013711 (2009)","journal-title":"Ann. Occup. Hyg."},{"key":"51_CR9","doi-asserted-by":"crossref","unstructured":"Kopjar, N. Garaj-Vrhovac, V. Kasuba, V. Rozgaj, R. Ramic, S. Pavlica, V. Zeljezic, D.: Assessment of genotoxic risk in Croation health care workers occupationally exposed to cytotoxic drugs: a multi-biomaker approach. ScienceDirect revista, 414\u2013431 (2009)","DOI":"10.1016\/j.ijheh.2008.10.001"},{"key":"51_CR10","doi-asserted-by":"crossref","unstructured":"Bouraoui, S. Brahem, A. Tabka, F. Mrizek, N. Saad, A. Elghezal, H.: Assessment of chromosomal aberrations, micronuclei and proliferation rate \u00edndex in peripheral lyphocytes from Tunisian nurses handling cytotoxic drugs. ScienceDirect revista, 250\u2013257 (2011)","DOI":"10.1016\/j.etap.2010.11.004"},{"issue":"1","key":"51_CR11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00420-012-0742-z","volume":"86","author":"B Kopp","year":"2013","unstructured":"Kopp, B., Schierl, R., Nowak, D.: Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings. Int. Arch. Occup. Environ. Health 86(1), 47\u201355 (2013)","journal-title":"Int. Arch. Occup. Environ. Health"},{"issue":"6","key":"51_CR12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3322\/canjclin.56.6.354","volume":"56","author":"TH Connor","year":"2006","unstructured":"Connor, T.H., McDiarmid, M.A.: Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J. Clin. 56(6), 354\u2013365 (2006)","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"51_CR13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00420-007-0181-4","volume":"80","author":"EEM Brouwers","year":"2007","unstructured":"Brouwers, E.E.M., Huitema, A.D.R., Bakker, E.N., Douma, J.W., Schimmel, K.J.M., van Weringh, G., Beijnen, J.H.: Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. Int. Arch. Occup. Environ. Health 80(8), 689\u2013699 (2007)","journal-title":"Int. Arch. Occup. Environ. Health"},{"issue":"5","key":"51_CR14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/B205132J","volume":"4","author":"O Nygren","year":"2002","unstructured":"Nygren, O., Gustavsson, B., Str\u00f6m, L., Eriksson, R., Jarneborn, L., Friberg, A.: Exposure to anti-cancer drugs during preparation and administration. Investigations of an open and a closed system. J. Environ. Monit. JEM 4(5), 739\u2013742 (2002)","journal-title":"J. Environ. Monit. JEM"},{"key":"51_CR15","doi-asserted-by":"crossref","unstructured":"Clark, B.A, & Sessink, P.J.: Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents. J. Oncol. Pharm. Pract. 19(2), 99\u2013104 (2013)","DOI":"10.1177\/1078155212468367"}],"container-title":["Advances in Intelligent Systems and Computing","Advances in Safety Management and Human Factors"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-41929-9_51","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T10:55:34Z","timestamp":1568112934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-41929-9_51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319419282","9783319419299"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-41929-9_51","relation":{},"ISSN":["2194-5357","2194-5365"],"issn-type":[{"type":"print","value":"2194-5357"},{"type":"electronic","value":"2194-5365"}],"subject":[],"published":{"date-parts":[[2016]]}}}